Emerging therapeutic options in inflammatory bowel disease

doi:10.3748/wjg.v27.i48.8242

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 27, Issue 48

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7134)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

502

WORD

106

HTML

4454

Figures (1-1)

496

Tables (1-1)

315

Sum=5873

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

402

Download

859

Sum=1261

Dec 28, 2021 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (16)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Dec 28, 2021; 27(48): 8242-8261
Published online Dec 28, 2021. doi: 10.3748/wjg.v27.i48.8242

Open in New Tab Full Size Figure Download Figure

Figure 1 Mechanism of action of new therapies in inflammatory bowel disease. JAK: Janus kinase; TLR: Toll like receptor; IL: Interleukin; S1P1: Sphingosine-1-phosphate; PDE4: Phosphodiesterase-4; TNF: Tumor necrosis factor.

Citation: Yamamoto-Furusho JK, Parra-Holguín NN. Emerging therapeutic options in inflammatory bowel disease. World J Gastroenterol 2021; 27(48): 8242-8261
URL: https://www.wjgnet.com/1007-9327/full/v27/i48/8242.htm
DOI: https://dx.doi.org/10.3748/wjg.v27.i48.8242